AI Assistance for Cognitive Overload
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how artificial intelligence (AI) can reduce the mental effort doctors experience when writing case reports about rare medical events. Participants will review two rare tumor cases and write about them—once with AI assistance and once without. The trial seeks medical students, resident doctors, and practicing physicians who often handle these complex cases. Those who fit this profile and wish to see if AI simplifies case reporting may find this trial suitable. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could transform medical documentation practices.
Do I need to stop taking my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems unlikely since the study focuses on cognitive tasks and AI assistance, not on medication effects.
What prior data suggests that this AI tool is safe for reducing cognitive burden?
Research has shown that artificial intelligence (AI) in healthcare can reduce the mental effort required for tasks. For example, one study found that AI tools helped healthcare workers manage tasks more efficiently, reducing stress and the risk of burnout. Another study demonstrated that AI improved decision-making and accuracy, enhancing workplace safety for healthcare workers. Although these studies focus on different areas, they suggest that AI tools are generally well-received and can alleviate mental strain. In this trial, AI assists in writing case reports, potentially lessening the mental workload for medical professionals. No specific reports of negative effects have emerged from using AI in these situations.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how artificial intelligence (AI) can assist medical professionals in managing cognitive overload. Unlike traditional methods where doctors rely solely on their expertise and available resources to make decisions, this AI-driven approach aims to enhance decision-making by quickly analyzing complex medical data and suggesting potential diagnoses or treatment options. This could significantly reduce the time and mental effort required for doctors to report rare cases, allowing for faster and possibly more accurate medical insights.
What evidence suggests that AI assistance is effective for reducing cognitive burden in case report writing?
Research has shown that artificial intelligence (AI) tools can ease the mental strain of processing excessive information. One study found that AI-based tools kept students engaged and reduced their mental overload. Another review demonstrated that AI tools increased work efficiency and improved writing quality. Additionally, AI use in education has positively impacted the training of health professionals. In this trial, one group of participants will use AI to assist in writing case reports, while another group will write case reports without AI assistance. These findings suggest that AI could help doctors manage the mental load of writing case reports.16789
Who Is on the Research Team?
Shivani Sud
Principal Investigator
UNC Lineberger Comprehensive Cancer Center
Are You a Good Fit for This Trial?
This trial is for physicians, medical students, or postdoctoral students. It's designed to see if AI can help reduce the mental effort they use when writing about rare tumor cases.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Single Session
Participants review two rare tumor cases and write a clinical vignette with and without AI assistance
Follow-up
Participants are monitored for cognitive workload and perceived cognitive load using NASA-TLX and SUS
What Are the Treatments Tested in This Trial?
Interventions
- Artificial Intelligence
Find a Clinic Near You
Who Is Running the Clinical Trial?
UNC Lineberger Comprehensive Cancer Center
Lead Sponsor